Login to Your Account



Shire CEO: Abbvie offer fails to consider new 'trajectory'

By Nuala Moran
Staff Writer

Monday, June 23, 2014
LONDON – Claiming to have "transformed" the company since becoming CEO a year ago, Flemming Ornskov set out the case for how his stewardship of Shire plc can deliver greater value to shareholders than agreeing to Abbvie Inc.'s $46 billion offer.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription